The risk of heart valve damage with two drugs for Parkinson’s disease may be far greater than was known, new research suggests. The drugs are not the main treatment for Parkinson’s, but one is also ...
The FDA recently announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease and pituitary adenomas, will voluntarily remove these drugs from the market ...
NEW YORK (Reuters Health) - Two "dopamine agonist" drugs commonly used to treat Parkinson's disease -- pergolide (Permax; Eli Lily) and cabergoline (Dostinex; Pfizer) -- may raise the risk of heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback